Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Clin Cancer Res. 2020 Oct 13;27(5):1227–1235. doi: 10.1158/1078-0432.CCR-20-2584

Figure 1. B7-H3 expression on tumorigenic cancer initiating cells isolated from human cancer cell lines.

Figure 1.

High ALDH activity (ALDHbright cells) is used as a marker to identify cancer initiating cells (CICs). Immunodeficient NOD/SCID mice were challenged with 500 ALDHbright and ALDHneg cells sorted from a (A) HNSCC or (B) PDAC cell line. In both models, tumors developed only in anatomic sites injected with ALDHbright cells, but not ALDHneg tumor cells. CICs from HNSCC (JHU029) and PDAC (PDAC3) human cell lines stained with the B7-H3-specific mAb 376.96 demonstrate high B7-H3 expression (C). ALDH: aldehyde dehydrogenase; HNSCC: head and neck squamous cell cancer; PDAC: pancreatic ductal adenocarcinoma. ALDHbright cells are identified as those ALDH+ cells with twice the mean fluorescence intensity of the ALDH+ population.